Relationships between hyperinsulinaemia, magnesium, vitamin D, thrombosis and COVID-19: rationale for clinical

Isabella D Cooper1, Catherine A P Crofts2, James J DiNicolantonio3

  • 1School of Life Sciences, University of Westminster - Cavendish Campus, London, UK bellamitochondria@gmail.com.

Open Heart
|September 17, 2020
PubMed

Insights

Hyperinsulinaemia, a risk factor in COVID-19, drives poor outcomes by promoting inflammation and thrombosis. Dietary carbohydrate restriction with magnesium, vitamin D, and zinc supplementation can manage these risks.

Area of Science:

  • Endocrinology
  • Metabolic Syndrome
  • COVID-19 Pathophysiology

Background:

  • Pre-existing conditions like obesity, type 2 diabetes, and cardiovascular disease are linked to severe COVID-19 outcomes.
  • Hyperinsulinaemia is identified as a common underlying factor contributing to these conditions and associated thrombotic events.
  • Vitamin D activation is dependent on magnesium, and hyperinsulinaemia disrupts this process.

Purpose of the Study:

  • To elucidate the role of hyperinsulinaemia in COVID-19 pathophysiology, particularly its links to thrombosis and poor outcomes.
  • To propose a theoretical management algorithm for frontline practitioners based on the underlying science.
  • To investigate the impact of hyperinsulinaemia on magnesium and vitamin D status.

Main Methods:

  • Review of existing scientific literature on hyperinsulinaemia, metabolic dysfunction, and COVID-19.
  • Analysis of biochemical pathways linking hyperinsulinaemia to inflammation, coagulation, and thrombosis.
  • Development of a management strategy based on dietary and supplemental interventions.

Main Results:

  • Hyperinsulinaemia contributes to thrombosis via fibrinolysis inhibition, dysregulated anticoagulation, oxidative stress, and decreased antioxidant capacity.
  • It also impairs vitamin D activation by depleting magnesium and sequestering vitamin D in adipocytes.
  • Hyperinsulinaemia-induced changes in cholesterol metabolism and cell membrane charge increase agglutination and thrombosis risk.

Conclusions:

  • Restricting refined carbohydrates in COVID-19 patients with hyperglycaemia/hyperinsulinaemia can rapidly manage key risk factors.
  • This dietary intervention, alongside magnesium, vitamin D, and zinc supplementation, addresses hyperinsulinaemia, hyperglycaemia, and hypertension, thereby reducing inflammation and thrombosis risk.
  • The proposed management algorithm offers a practical approach for frontline practitioners to mitigate severe COVID-19 outcomes.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
762
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
94
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
311
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
550
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.1K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
225